annual EBIT:
-$534.26M-$18.97M(-3.68%)Summary
- As of today (August 18, 2025), NTLA annual earnings before interest & taxes is -$534.26 million, with the most recent change of -$18.97 million (-3.68%) on December 31, 2024.
- During the last 3 years, NTLA annual EBIT has fallen by -$266.41 million (-99.46%).
- NTLA annual EBIT is now -15234.76% below its all-time high of -$3.48 million, reached on December 31, 2014.
Performance
NTLA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$110.00M+$10.81M(+8.95%)Summary
- As of today (August 18, 2025), NTLA quarterly earnings before interest & taxes is -$110.00 million, with the most recent change of +$10.81 million (+8.95%) on June 30, 2025.
- Over the past year, NTLA quarterly EBIT has increased by +$29.05 million (+20.89%).
- NTLA quarterly EBIT is now -9104.69% below its all-time high of -$1.20 million, reached on March 31, 2015.
Performance
NTLA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$512.02M+$29.05M(+5.37%)Summary
- As of today (August 18, 2025), NTLA TTM earnings before interest & taxes is -$512.02 million, with the most recent change of +$29.05 million (+5.37%) on June 30, 2025.
- Over the past year, NTLA TTM EBIT has increased by +$12.03 million (+2.29%).
- NTLA TTM EBIT is now -42746.86% below its all-time high of -$1.20 million, reached on March 31, 2015.
Performance
NTLA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NTLA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.7% | +20.9% | +2.3% |
| 3 y3 years | -99.5% | -11.9% | -29.6% |
| 5 y5 years | -402.3% | -233.0% | -322.5% |
NTLA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | at low | -11.9% | +24.0% | -29.6% | +5.4% |
| 5 y | 5-year | -402.3% | at low | -291.4% | +24.0% | -322.5% | +5.4% |
| alltime | all time | <-9999.0% | at low | -9104.7% | +24.0% | <-9999.0% | +5.4% |
NTLA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$110.00M(-8.9%) | -$512.02M(-5.4%) |
| Mar 2025 | - | -$120.81M(-11.5%) | -$541.07M(+1.3%) |
| Dec 2024 | -$534.26M(+3.7%) | -$136.45M(-5.7%) | -$534.26M(-0.6%) |
| Sep 2024 | - | -$144.77M(+4.1%) | -$537.71M(+2.6%) |
| Jun 2024 | - | -$139.04M(+22.0%) | -$524.04M(+1.3%) |
| Mar 2024 | - | -$114.00M(-18.5%) | -$517.34M(+0.4%) |
| Dec 2023 | -$515.29M(+12.5%) | -$139.89M(+6.7%) | -$515.29M(+6.1%) |
| Sep 2023 | - | -$131.11M(-0.9%) | -$485.49M(+5.6%) |
| Jun 2023 | - | -$132.33M(+18.2%) | -$459.91M(+8.0%) |
| Mar 2023 | - | -$111.96M(+1.7%) | -$425.88M(-7.0%) |
| Dec 2022 | -$458.16M(+71.1%) | -$110.09M(+4.3%) | -$458.16M(+6.9%) |
| Sep 2022 | - | -$105.53M(+7.4%) | -$428.49M(+8.5%) |
| Jun 2022 | - | -$98.30M(-31.9%) | -$394.95M(+8.0%) |
| Mar 2022 | - | -$144.25M(+79.4%) | -$365.67M(+36.5%) |
| Dec 2021 | -$267.85M(+96.1%) | -$80.42M(+11.7%) | -$267.85M(+16.5%) |
| Sep 2021 | - | -$71.99M(+4.3%) | -$229.83M(+23.6%) |
| Jun 2021 | - | -$69.02M(+48.7%) | -$185.94M(+24.0%) |
| Mar 2021 | - | -$46.42M(+9.5%) | -$149.96M(+9.8%) |
| Dec 2020 | -$136.58M | -$42.40M(+50.9%) | -$136.58M(+10.2%) |
| Sep 2020 | - | -$28.10M(-14.9%) | -$123.95M(+2.3%) |
| Jun 2020 | - | -$33.03M(-0.0%) | -$121.18M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$33.05M(+11.0%) | -$115.61M(+8.7%) |
| Dec 2019 | -$106.37M(+17.1%) | -$29.77M(+17.5%) | -$106.37M(+9.3%) |
| Sep 2019 | - | -$25.33M(-7.8%) | -$97.34M(+1.3%) |
| Jun 2019 | - | -$27.46M(+15.3%) | -$96.11M(+4.2%) |
| Mar 2019 | - | -$23.81M(+14.8%) | -$92.25M(+1.5%) |
| Dec 2018 | -$90.87M(+30.6%) | -$20.75M(-13.9%) | -$90.87M(-4.2%) |
| Sep 2018 | - | -$24.10M(+2.1%) | -$94.84M(+9.5%) |
| Jun 2018 | - | -$23.59M(+5.2%) | -$86.61M(+9.6%) |
| Mar 2018 | - | -$22.43M(-9.2%) | -$79.04M(+13.6%) |
| Dec 2017 | -$69.56M(+116.3%) | -$24.71M(+55.7%) | -$69.56M(+25.0%) |
| Sep 2017 | - | -$15.88M(-0.9%) | -$55.66M(+17.2%) |
| Jun 2017 | - | -$16.02M(+23.7%) | -$47.48M(+23.6%) |
| Mar 2017 | - | -$12.95M(+19.6%) | -$38.41M(+19.4%) |
| Dec 2016 | -$32.16M(+139.8%) | -$10.82M(+40.6%) | -$32.16M(+19.9%) |
| Sep 2016 | - | -$7.70M(+10.8%) | -$26.83M(+19.6%) |
| Jun 2016 | - | -$6.95M(+3.8%) | -$22.43M(+18.6%) |
| Mar 2016 | - | -$6.69M(+21.9%) | -$18.91M(+41.0%) |
| Dec 2015 | -$13.41M(+284.9%) | -$5.49M(+66.3%) | -$13.41M(+69.3%) |
| Sep 2015 | - | -$3.30M(-3.5%) | -$7.92M(+71.5%) |
| Jun 2015 | - | -$3.42M(+186.4%) | -$4.62M(+286.4%) |
| Mar 2015 | - | -$1.20M | -$1.20M |
| Dec 2014 | -$3.48M | - | - |
FAQ
- What is Intellia Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual EBIT year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Intellia Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM EBIT year-on-year change?
What is Intellia Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of NTLA is -$534.26M
What is the all time high annual EBIT for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$3.48M
What is Intellia Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, NTLA annual earnings before interest & taxes has changed by -$18.97M (-3.68%)
What is Intellia Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of NTLA is -$110.00M
What is the all time high quarterly EBIT for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$1.20M
What is Intellia Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, NTLA quarterly earnings before interest & taxes has changed by +$29.05M (+20.89%)
What is Intellia Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of NTLA is -$512.02M
What is the all time high TTM EBIT for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$1.20M
What is Intellia Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, NTLA TTM earnings before interest & taxes has changed by +$12.03M (+2.29%)